» Articles » PMID: 17618679

Further Evidence That the Delayed Temporal Dopaminergic Effects of LSD Are Mediated by a Mechanism Different Than the First Temporal Phase of Action

Overview
Publisher Elsevier
Date 2007 Jul 10
PMID 17618679
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Activation of 5-HT(2A) receptors is thought to mediate the hallucinogenic effects of LSD. Nevertheless, in a previous report we provided evidence that a delayed temporal phase of the behavioral pharmacology of LSD is mediated by D(2)-like dopamine receptor stimulation. In this study rats were trained to discriminate LSD with either a 30 min preinjection time (LSD-30, N=12) or a 90 min preinjection time (LSD-90, N=13) from saline, using a two-lever, food-reinforced operant conditioning task. We then tested a large number of agonists and antagonists belonging to distinct pharmacological classes in these animals. As anticipated, classical hallucinogens such as psilocin and mescaline substituted only in LSD-30 rats, and not in LSD-90 rats. The dopamine receptor agonists ABT-724, aripiprazole, dihydrexidine, WAY 100635, and SKF 38393, fully or partially mimicked LSD-90, but not LSD-30. The results reported here support and extend our previous conclusion that the delayed temporal effects of LSD are mediated by activation of a dopaminergic system.

Citing Articles

Whole brain modelling for simulating pharmacological interventions on patients with disorders of consciousness.

Mindlin I, Herzog R, Belloli L, Manasova D, Monge-Asensio M, Vohryzek J Commun Biol. 2024; 7(1):1176.

PMID: 39300281 PMC: 11413186. DOI: 10.1038/s42003-024-06852-9.


A Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics.

Banushi B, Polito V Biology (Basel). 2023; 12(11).

PMID: 37997979 PMC: 10669348. DOI: 10.3390/biology12111380.


Acute effects of MDMA and LSD co-administration in a double-blind placebo-controlled study in healthy participants.

Straumann I, Ley L, Holze F, Becker A, Klaiber A, Wey K Neuropsychopharmacology. 2023; 48(13):1840-1848.

PMID: 37258715 PMC: 10584820. DOI: 10.1038/s41386-023-01609-0.


Language as a Window Into the Altered State of Consciousness Elicited by Psychedelic Drugs.

Tagliazucchi E Front Pharmacol. 2022; 13:812227.

PMID: 35392561 PMC: 8980225. DOI: 10.3389/fphar.2022.812227.


How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework.

van den Berg M, Magaraggia I, Schreiber R, Hillhouse T, Porter J Psychopharmacology (Berl). 2022; 239(6):1853-1879.

PMID: 35348806 PMC: 9166823. DOI: 10.1007/s00213-022-06106-8.